IHC of paraffin-embedded Carcinoma of Human thyroid tissue using anti-ILVBL mouse monoclonal antibody.
IHC of paraffin-embedded Human tonsil using anti-ILVBL mouse monoclonal antibody.
IHC of paraffin-embedded Carcinoma of Human liver tissue using anti-ILVBL mouse monoclonal antibody.
IHC of paraffin-embedded Carcinoma of Human bladder tissue using anti-ILVBL mouse monoclonal antibody.
IHC of paraffin-embedded Human prostate tissue using anti-ILVBL mouse monoclonal antibody.
IHC of paraffin-embedded Adenocarcinoma of Human endometrium tissue using anti-ILVBL mouse monoclonal antibody.
IHC of paraffin-embedded Human breast tissue using anti-ILVBL mouse monoclonal antibody.
IHC of paraffin-embedded Human pancreas tissue using anti-ILVBL mouse monoclonal antibody.
IHC of paraffin-embedded Adenocarcinoma of Human colon tissue using anti-ILVBL mouse monoclonal antibody.
IHC of paraffin-embedded Human liver tissue using anti-ILVBL mouse monoclonal antibody.
IHC of paraffin-embedded Human Kidney tissue using anti-ILVBL mouse monoclonal antibody.
Anti-ILVBL mouse monoclonal antibody immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY ILVBL.
Western blot of extracts (35 ug) from 9 different cell lines by using anti-ILVBL monoclonal antibody.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY ILVBL (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-ILVBL.
Flow cytometry of Jurkat cells, using anti-ILVBL antibody (Red), compared to a nonspecific negative control antibody (Blue).
Flow cytometry of HeLa cells, using anti-ILVBL antibody (Red), compared to a nonspecific negative control antibody (Blue).